Yen-Ju Lin

Motivated and disciplined biological researcher with 12+ years of experiences, including 4 years of drug development experiences at biopharmaceutical industry. Currently a PhD student at Paul-Ehrlich-Institute in Germany, investigating a flagellin-allergen fusion protein as a novel vaccine candidate for type-I allergy treatment. Current research focuses on intracellular signaling pathways, inflammasome activation, and immune metabolism.